EMEA-001359-PIP01-12-M03

Key facts

Active substance
Retosiban
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0162/2016
PIP number
EMEA-001359-PIP01-12-M03
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of spontaneous preterm labour
Route(s) of administration
Intravenous use
Contact for public enquiries
GlaxoSmithKline Trading Services Limited

Tel. +1 4388998201
E-mail: eu.paediatric-plans@gsk.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating